Agency Information Collection Request; 30-Day Public Comment Request, 6657-6658 [2021-01323]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 13 / Friday, January 22, 2021 / Notices
Coordinator for Health Information
Technology (National Coordinator). The
HITAC will hold public meetings
throughout 2021. See list of public
meetings below.
FOR FURTHER INFORMATION CONTACT:
Lauren Richie, Designated Federal
Officer, at Lauren.Richie@hhs.gov, (202)
205–7674.
SUPPLEMENTARY INFORMATION: Section
4003(e) of the 21st Century Cures Act
(Pub. L. 114–255) establishes the Health
Information Technology Advisory
Committee (referred to as the ‘‘HITAC’’).
The HITAC will be governed by the
provisions of the Federal Advisory
Committee Act (FACA) (Pub. L. 92–
463), as amended, (5 U.S.C. App.),
which sets forth standards for the
formation and use of federal advisory
committees.
Composition
The HITAC is comprised of at least 25
members, of which:
• No fewer than 2 members are
advocates for patients or consumers of
health information technology;
• 3 members are appointed by the
HHS Secretary;
Æ 1 of whom shall be appointed to
represent the Department of Health and
Human Services; and
Æ 1 of whom shall be a public health
official;
• 2 members are appointed by the
majority leader of the Senate;
• 2 members are appointed by the
minority leader of the Senate;
• 2 members are appointed by the
Speaker of the House of Representatives;
• 2 members are appointed by the
minority leader of the House of
Representatives; and
• Other members are appointed by
the Comptroller General of the United
States.
Members will serve for one-, two-, or
three-year terms. All members may be
reappointed for a subsequent three-year
term. Each member is limited to two
three-year terms, not to exceed six years
of service. Members serve without pay,
but will be provided per-diem and
travel costs for committee services, if
warranted.
jbell on DSKJLSW7X2PROD with NOTICES
Recommendations
The HITAC recommendations to the
National Coordinator are publicly
available at https://www.healthit.gov/
topic/federal-advisory-committees/
recommendations-national-coordinatorhealth-it.
Public Meetings
The schedule of meetings to be held
in 2021 is as follows:
VerDate Sep<11>2014
19:27 Jan 21, 2021
Jkt 253001
• January 13, 2021 from
approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
• February 10, 2021 from
approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
• March 10, 2021 from approximately
9:30 a.m. to 2:30 p.m./Eastern Time
(virtual meeting)
• April 15, 2021 from approximately
9:30 a.m. to 2:30 p.m./Eastern Time
(virtual meeting)
• May 13, 2021 from approximately
9:30 a.m. to 2:30 p.m./Eastern Time
(virtual meeting)
• June 9, 2021 from approximately
9:30 a.m. to 2:30 p.m./Eastern Time
(virtual meeting)
• July 14, 2021 from approximately
9:30 a.m. to 2:30 p.m./Easter Time
(virtual meeting)
• September 9, 2021 from
approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
• November 10, 2021 from
approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
All meetings are open to the public.
Additional meetings may be scheduled
as needed. For web conference
instructions and the most up-to-date
information, please visit the HITAC
calendar on the ONC website, https://
www.healthit.gov/topic/federaladvisory-committees/hitac-calendar.
Contact Person for Meetings: Lauren
Richie, Lauren.Richie@hhs.gov. A notice
in the Federal Register about last
minute modifications that impact a
previously announced advisory
committee meeting cannot always be
published quickly enough to provide
timely notice. Please email Lauren
Richie for the most current information
about meetings.
Agenda: As outlined in the 21st
Century Cures Act, the HITAC will
develop and submit recommendations
to the National Coordinator on the
topics of interoperability, privacy and
security, and patient access. In addition,
the committee will also address any
administrative matters and hear
periodic reports from ONC. ONC
intends to make background material
available to the public no later than 24
hours prior to the meeting start time. If
ONC is unable to post the background
material on its website prior to the
meeting, the material will be made
publicly available on ONC’s website
after the meeting, at https://
www.healthit.gov/hitac.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person prior to the meeting date. An
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
6657
oral public comment period will be
scheduled at each meeting. Time
allotted for each commenter will be
limited to three minutes. If the number
of speakers requesting to comment is
greater than can be reasonably
accommodated during the scheduled
public comment period, ONC will take
written comments after the meeting.
Persons attending in-person HITAC
meetings are advised that the agency is
not responsible for providing wireless
access or access to electrical outlets.
ONC welcomes the attendance of the
public at its HITAC meetings. Seating is
limited at in-person meetings, and ONC
will make every effort to accommodate
persons with physical disabilities or
special needs. If you require special
accommodations due to a disability,
please contact Lauren Richie at least
seven (7) days in advance of the
meeting.
Notice of these meetings are given
under the Federal Advisory Committee
Act (Pub. L. 92–463, 5 U.S.C., App. 2).
Dated: December 11, 2020.
Lauren Richie,
Designated Federal Officer, Office of the
National Coordinator for Health Information
Technology.
[FR Doc. 2021–01411 Filed 1–21–21; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–0990–New]
Agency Information Collection
Request; 30-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before February 22, 2021.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT:
Sherrette Funn, Sherrette.Funn@hhs.gov
or (202) 795–7714. When submitting
SUMMARY:
E:\FR\FM\22JAN1.SGM
22JAN1
6658
Federal Register / Vol. 86, No. 13 / Friday, January 22, 2021 / Notices
comments or requesting information,
please include the document identifier
0990–New–30D and project title for
reference.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: HHS
Teletracking COVID–19 Portal (U.S.
Healthcare COVID–19 Portal).
Type of Collection: In use without an
OMB number: OMB No. 0990–XXXX
OS/OCIO.
Abstract: The data collected through
this ICR informs the Federal
Government’s understanding of disease
patterns and furthers the development
of policies for prevention and control of
disease spread and impact related to the
2019 Novel Coronavirus (COVID–19).
One of the most important uses of the
data collected through this ICR is to
determine critical allocations of limited
supplies (e.g., protective equipment and
medication). For instance, this
collection has been used to distribute
Remdesivir, a vital therapeutic that HHS
distributes to the American healthcare
system, via distinct data calls on regular
intervals. As of July 10, HHS reduced
the number requests for data from
hospitals to support allocations of
Remdesivir. HHS has stopped sending
out one-time requests for data to aid in
the distribution of Remdesivir or any
other treatments or supplies. This
consolidated daily reporting is the only
mechanism used for the distribution
calculations, and daily reports are
needed to ensure accurate calculations.
Type of respondent: We acknowledge
the burden placed on many hospitals,
including resource constraints, and have
allowed for some flexibilities, such as
back-submissions or submitting every
business days, with the understanding
that respondents may not have
sufficient staff working over the
weekend. It is our belief that collection
of this information daily is the most
effective way to detect outbreaks and
needs for Federal assistance over time,
by hospital and geographical area, and
to alert the appropriate officials for
action. It’s requested that 5,500
hospitals, submit data daily on the
number of patients tested for COVID–19,
as well as information on bed capacity
and requirements for other supplies.
The HHS Teletracking COVID–19
Portal (U.S. Healthcare COVID–19
Portal) includes some data that were
initially submitted by hospitals to HHS
through CDC’s National Healthcare
Safety Network (NHSN) COVID–19
Module (OMB Control No. 0920–1290,
approved 03/26/2020). Over the last
several months time, the guidance for
which data elements should be sent to
HHS and through which method was
updated at the request of the White
House Coronavirus Task Force and
other leaders to better inform the
response.
ANNUALIZED BURDEN HOUR TABLE
Average
burden per
response
(in hours)
Total burden
hours
Form name
Hospitals ...........................................
HHS Teletracking COVID–19 Portal
(U.S. Healthcare COVID–19 Portal).
5,500
365
1.5
3,011,250
Total ...........................................
...........................................................
........................
........................
........................
3,011,250
Dated: January 14, 2021.
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2021–01323 Filed 1–21–21; 8:45 am]
BILLING CODE 4150–04–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
jbell on DSKJLSW7X2PROD with NOTICES
Number
responses per
respondent
Number of
respondents
Type of respondent
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
VerDate Sep<11>2014
19:27 Jan 21, 2021
Jkt 253001
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Obstetrics and Maternal-Fetal
Biology Subcommittee.
Date: March 5, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6710B
Rockledge Drive, Bethesda, MD 20817
(Video-Assisted Meeting).
Contact Person: Luis E. Dettin, Ph.D., M.S.,
M.A., Scientific Review Officer, Scientific
Review Branch, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6710B Rockledge
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Drive, Rm. 2131B, Bethesda, MD 20892, (301)
827–8231, luis_dettin@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.865, Research for Mothers
and Children, National Institutes of Health,
HHS)
Dated: January 14, 2021.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–01262 Filed 1–21–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\22JAN1.SGM
22JAN1
]]>Agencies
[Federal Register Volume 86, Number 13 (Friday, January 22, 2021)]
[Notices]
[Pages 6657-6658]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-01323]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Document Identifier: OS-0990-New]
Agency Information Collection Request; 30-Day Public Comment
Request
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995, the Office of the Secretary (OS), Department of Health and
Human Services, is publishing the following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be received on or before February 22,
2021.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: Sherrette Funn, [email protected]
or (202) 795-7714. When submitting
[[Page 6658]]
comments or requesting information, please include the document
identifier 0990-New-30D and project title for reference.
SUPPLEMENTARY INFORMATION: Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
Title of the Collection: HHS Teletracking COVID-19 Portal (U.S.
Healthcare COVID-19 Portal).
Type of Collection: In use without an OMB number: OMB No. 0990-XXXX
OS/OCIO.
Abstract: The data collected through this ICR informs the Federal
Government's understanding of disease patterns and furthers the
development of policies for prevention and control of disease spread
and impact related to the 2019 Novel Coronavirus (COVID-19). One of the
most important uses of the data collected through this ICR is to
determine critical allocations of limited supplies (e.g., protective
equipment and medication). For instance, this collection has been used
to distribute Remdesivir, a vital therapeutic that HHS distributes to
the American healthcare system, via distinct data calls on regular
intervals. As of July 10, HHS reduced the number requests for data from
hospitals to support allocations of Remdesivir. HHS has stopped sending
out one-time requests for data to aid in the distribution of Remdesivir
or any other treatments or supplies. This consolidated daily reporting
is the only mechanism used for the distribution calculations, and daily
reports are needed to ensure accurate calculations.
Type of respondent: We acknowledge the burden placed on many
hospitals, including resource constraints, and have allowed for some
flexibilities, such as back-submissions or submitting every business
days, with the understanding that respondents may not have sufficient
staff working over the weekend. It is our belief that collection of
this information daily is the most effective way to detect outbreaks
and needs for Federal assistance over time, by hospital and
geographical area, and to alert the appropriate officials for action.
It's requested that 5,500 hospitals, submit data daily on the number of
patients tested for COVID-19, as well as information on bed capacity
and requirements for other supplies.
The HHS Teletracking COVID-19 Portal (U.S. Healthcare COVID-19
Portal) includes some data that were initially submitted by hospitals
to HHS through CDC's National Healthcare Safety Network (NHSN) COVID-19
Module (OMB Control No. 0920-1290, approved 03/26/2020). Over the last
several months time, the guidance for which data elements should be
sent to HHS and through which method was updated at the request of the
White House Coronavirus Task Force and other leaders to better inform
the response.
Annualized Burden Hour Table
----------------------------------------------------------------------------------------------------------------
Average
Number of Number burden per Total burden
Type of respondent Form name respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Hospitals..................... HHS Teletracking 5,500 365 1.5 3,011,250
COVID-19 Portal
(U.S.
Healthcare
COVID-19
Portal).
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 3,011,250
----------------------------------------------------------------------------------------------------------------
Dated: January 14, 2021.
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance Officer, Office of the
Secretary.
[FR Doc. 2021-01323 Filed 1-21-21; 8:45 am]
BILLING CODE 4150-04-P
